2013
DOI: 10.2146/ajhp120728
|View full text |Cite
|
Sign up to set email alerts
|

Biological contamination of insulin pens in a hospital setting

Abstract: Examination of 125 insulin pens used in hospitals revealed hemoglobin in 1 pen and at least one cell in another 6 pens. The nine detected cells consisted of four squamous epithelial cells, four macrophages, and one RBC.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
19
0
3

Year Published

2015
2015
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(22 citation statements)
references
References 16 publications
0
19
0
3
Order By: Relevance
“…Moreover, to fully protect patients and health workers, adequate nurses training is essential to eliminate the risk of transmission of infectious diseases associated with pens misuse. In fact, more than 700 patients in New York hospitals may have been exposed inadvertently to human immunodeficiency virus (HIV), hepatitis B or hepatitis C because of reuse of insulin pens on multiple patients after changing the disposable needle [28]. Patient notification events resulting from multipatient use of insulin pens in U.S. health care settings were recently summarized [29].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, to fully protect patients and health workers, adequate nurses training is essential to eliminate the risk of transmission of infectious diseases associated with pens misuse. In fact, more than 700 patients in New York hospitals may have been exposed inadvertently to human immunodeficiency virus (HIV), hepatitis B or hepatitis C because of reuse of insulin pens on multiple patients after changing the disposable needle [28]. Patient notification events resulting from multipatient use of insulin pens in U.S. health care settings were recently summarized [29].…”
Section: Discussionmentioning
confidence: 99%
“…Patient notification events resulting from multipatient use of insulin pens in U.S. health care settings were recently summarized [29]. It is unquestionable that each pen is absolutely for personal usage only, and it must be labeled with the name of the patient; in fact, in the final phase of insulin delivery, an aspiration of material occurs: this may contaminate the pen, as shown by several observations, and also in a recent study who demonstrated trace of biological contamination (hemoglobin, squamous epithelial cells, macrophages and RBC) in the pen after use [28]. As recommended by the Institute for Safe Medication Practices, all the study nurses performed a training period before using pens, which also included a hands-on individual testing of devices.…”
Section: Discussionmentioning
confidence: 99%
“…Reports have included technique-related concerns such as improper priming, failure to "tip and roll" suspensions, use of the pen as a multiple-dose vial, incorrect injection method, misinterpretation of fluid on the skin after an injection as delivery of a partial dose, needlestick injury, and the potential for blood-borne pathogen transmission if insulin pens are used intentionally or inadvertently in more than one patient. 11,[16][17][18][19][20][21][22][23][24][25][26][27][28][29] In response to reports of insulin pen misuse in more than one patient, the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) issued communications intended to notify healthcare professionals and the public about the potential for transmission of hepatitis B and C viruses, HIV, and other blood-borne pathogens, with recommendations for mitigating the risk of misuse. 30,31 An expert consensus panel convened by the ASHP Research and Education Foundation identified 10 practical recommendations to enhance insulin-use safety throughout the medication-use process in hospitals.…”
Section: Facilitating the Safe Use Of Insulin Pens In Hospitalsmentioning
confidence: 99%
“…Conversely, whether insulin pen devices should replace traditional vial and syringe in hospitalized patients is still a controversial subject [3]. Together with patients’ satisfaction [4, 5], economic evaluation [46] and safety issues related to the potential risk of biological contaminations for both nurses and patients [57], nurses’ satisfaction constitutes a key perspective for the management of hospitalized patients with diabetes requiring insulin injections. However, information on this topic is scarce, with the only data coming from the US, where 70 % of nurses considered insulin pens an “improvement” over conventional vial and syringe method 11 months after their introduction in two floors of one hospital [8].…”
Section: Introductionmentioning
confidence: 99%